Compliance Rate

Compliance Rate 60.0%
Compliant submissions 60
Incompliant submissions 40
Total trials 100

Your Clinical Trials

Showing 50 of 100 entries
View as:

HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00000799 Org: User:
Start: - End: 04/30/96 Due: 04/30/97

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

Phase: N/A Priority: Normal
NCT ID: NCT00000649 Org: User:
Start: - End: - Due: -

Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)

Phase: N/A Priority: Normal
NCT ID: NCT00000379 Org: User:
Start: 01/31/99 End: 12/31/03 Due: 12/31/04

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000669 Org: User:
Start: - End: - Due: -

Dietary Intervention Study in Children (DISC)

Phase: N/A Priority: Normal
NCT ID: NCT00000459 Org: User:
Start: 12/31/86 End: 01/31/99 Due: 01/31/00

Potassium and Sodium to Control Blood Pressure in Hypertensives

Phase: N/A Priority: Normal
NCT ID: NCT00000509 Org: User:
Start: 09/30/83 End: 09/30/03 Due: 09/30/04

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Phase: N/A Priority: Normal
NCT ID: NCT00000549 Org: User:
Start: 08/31/94 End: 07/31/00 Due: 07/31/01

Maintenance Therapies in Bipolar Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00000369 Org: User:
Start: 06/30/97 End: 12/31/02 Due: 12/31/03

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)

Phase: N/A Priority: Normal
NCT ID: NCT00000819 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT00000759 Org: User:
Start: - End: - Due: -

Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

Phase: N/A Priority: Normal
NCT ID: NCT00000359 Org: User:
Start: 10/31/98 End: 06/30/03 Due: 06/30/04

A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000909 Org: User:
Start: - End: 06/30/04 Due: 06/30/05

(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000679 Org: User:
Start: - End: - Due: -

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000719 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

Herpetic Eye Disease Study (HEDS) II

Phase: N/A Priority: Normal
NCT ID: NCT00000139 Org: User:
Start: 10/31/92 End: - Due: -

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

Phase: N/A Priority: Normal
NCT ID: NCT00000659 Org: User:
Start: - End: - Due: -

A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible

Phase: N/A Priority: Normal
NCT ID: NCT00000939 Org: User:
Start: - End: 01/31/00 Due: 01/31/01

A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000949 Org: User:
Start: - End: 07/31/00 Due: 07/31/01

Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)

Phase: N/A Priority: Normal
NCT ID: NCT00000619 Org: User:
Start: 04/30/01 End: 03/31/06 Due: 03/31/07

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000959 Org: User:
Start: - End: 06/30/96 Due: 06/30/97

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000989 Org: User:
Start: - End: 07/31/92 Due: 07/31/93

Infusion Laboratory: Protocol 5 (Flupenthixol) - 14

Phase: N/A Priority: Normal
NCT ID: NCT00000349 Org: User:
Start: - End: - Due: -

Trial to Reduce Alloimmunization to Platelets (TRAP)

Phase: N/A Priority: Normal
NCT ID: NCT00000589 Org: User:
Start: 08/31/89 End: 07/31/97 Due: 07/31/98

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Phase: N/A Priority: Normal
NCT ID: NCT00000319 Org: User:
Start: 06/30/96 End: 01/31/05 Due: 01/31/06

Asymptomatic Carotid Artery Plaque Study (ACAPS)

Phase: N/A Priority: Normal
NCT ID: NCT00000469 Org: User:
Start: 05/31/88 End: 08/31/98 Due: 08/31/99